New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 34 (1) , 9-16
- https://doi.org/10.1016/s0009-9120(00)00175-2
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1Transplantation, 1999
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1998
- The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive TherapyClinical Pharmacokinetics, 1996
- Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 yearNephrology Dialysis Transplantation, 1996
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve MonitoringTherapeutic Drug Monitoring, 1995
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994
- Consensus Document: Hawk's Cay Meeting on Therapeutic Drug Monitoring of CyclosporineClinical Chemistry, 1990